Literature DB >> 33617309

Mending Broken Hearts: A New Treatment Paradigm for Immune Checkpoint Inhibitor-Induced Myocarditis.

Bonnie L Bermas1,2, Vlad G Zaha3,4,5,2.   

Abstract

Entities:  

Keywords:  immune checkpoint inhibitors; myocarditis

Mesh：

Substances：

Year:  2021        PMID： 33617309     DOI： 10.1161/CIRCULATIONAHA.120.052307

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  3 in total

Review 1.  TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis.

Authors:  Xiaohang Liu; Wei Wu; Ligang Fang; Yingxian Liu; Wei Chen
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

2.  Immunomodulating Therapies in Acute Myocarditis and Recurrent/Acute Pericarditis.

Authors:  Enrico Ammirati; Emanuele Bizzi; Giacomo Veronese; Matthieu Groh; Caroline M Van de Heyning; Jukka Lehtonen; Marc Pineton de Chambrun; Alberto Cereda; Chiara Picchi; Lucia Trotta; Javid J Moslehi; Antonio Brucato
Journal:  Front Med (Lausanne)       Date:  2022-03-07

3.  Myocarditis Following Immune Checkpoint Inhibition With Pembrolizumab: Management in a Context of Steroid Intolerance.

Authors:  Laura L Onderko; Ross Heinrich; Katalin Gosling; Tim Downs; Maxwell Eyram Afari
Journal:  CJC Open       Date:  2022-07-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.